Gateway Wealth Partners’s Pfizer PFE Stock Holding History

Gateway Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$479K	Sell	19,883 -23,708	-54%	-$620K	0.03%	475
2026 Q1	$1.22M	Buy	43,591 +33,532	+333%	+$893K	0.05%	337
2025 Q4	$250K	Buy	10,059 +959	+11%	+$24.2K	0.03%	405
2025 Q3	$232K	Buy	+9,100	New	+$225K	0.03%	373
2024 Q3	–	Sell	-7,176	Closed	-$201K	–	288
2024 Q2	$201K	Sell	7,176 -1,876	-21%	-$51.6K	0.06%	257
2024 Q1	$251K	Sell	9,052 -499	-5%	-$13.8K	0.09%	193
2023 Q4	$275K	Sell	9,551 -10,508	-52%	-$318K	0.11%	166
2023 Q3	$665K	Sell	20,059 -1,045	-5%	-$37K	0.12%	108
2023 Q2	$774K	Buy	21,104 +979	+5%	+$38.1K	0.14%	93
2023 Q1	$821K	Buy	20,125 +1,936	+11%	+$83.6K	0.13%	84
2022 Q4	$932K	Buy	+18,189	New	+$872K	0.16%	71

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gateway Wealth Partners's PFE Position: Q2 2026 in Review

Gateway Wealth Partners reduced its Pfizer (PFE) stake by 54% in Q2 2026, selling an estimated $620K and leaving 19,883 shares worth $479K. The position accounts for 0.03% of the portfolio, ranked #475.

Gateway Wealth Partners first reported a position in PFE in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.22M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Gateway Wealth Partners held 19,883 shares of Pfizer worth $479K as of Q2 2026.
Gateway Wealth Partners sold 23,708 Pfizer shares in Q2 2026, an estimated $620K.
Pfizer made up 0.03% of Gateway Wealth Partners's portfolio in Q2 2026, its #475 holding.
Gateway Wealth Partners first reported a position in Pfizer in Q4 2022 and has held it in 11 quarters since.
Gateway Wealth Partners's Pfizer position peaked at $1.22M in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.